Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 152

1.

The persisting burden of invasive pneumococcal disease in HIV patients: an observational cohort study.

Siemieniuk RA, Gregson DB, Gill MJ.

BMC Infect Dis. 2011 Nov 11;11:314. doi: 10.1186/1471-2334-11-314.

PMID:
22078162
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Trends in mortality and antibiotic resistance among HIV-infected patients with invasive pneumococcal disease.

Grau I, Ardanuy C, Liñares J, Podzamczer D, Schulze MH, Pallares R.

HIV Med. 2009 Sep;10(8):488-95. doi: 10.1111/j.1468-1293.2009.00717.x. Epub 2009 May 6.

PMID:
19459987
[PubMed - indexed for MEDLINE]
3.

Invasive pneumococcal disease among HIV-positive individuals, 2000-2009.

Yin Z, Rice BD, Waight P, Miller E, George R, Brown AE, Smith RD, Slack M, Delpech VC.

AIDS. 2012 Jan 2;26(1):87-94. doi: 10.1097/QAD.0b013e32834dcf27.

PMID:
22008657
[PubMed - indexed for MEDLINE]
4.

Invasive pneumococcal disease among human immunodeficiency virus-infected children, 1989-2006.

Steenhoff AP, Wood SM, Rutstein RM, Wahl A, McGowan KL, Shah SS.

Pediatr Infect Dis J. 2008 Oct;27(10):886-91. doi: 10.1097/INF.0b013e3181734f8f.

PMID:
18776825
[PubMed - indexed for MEDLINE]
5.

Invasive pneumococcal disease in HIV-infected adults: clinical changes after the introduction of the pneumococcal conjugate vaccine in children.

Burgos J, Peñaranda M, Payeras A, Villoslada A, Curran A, Garau M, Riera M, Crespo M, Navarro J, Van den Eynde E, Planes AM, Ribera E, Pahissa A, Falcó V.

J Acquir Immune Defic Syndr. 2012 Jan 1;59(1):31-8. doi: 10.1097/QAI.0b013e31823d0f5f.

PMID:
22156821
[PubMed - indexed for MEDLINE]
6.

Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy.

Grau I, Pallares R, Tubau F, Schulze MH, Llopis F, Podzamczer D, Liñares J, Gudiol F; Spanish Pneumococcal Infection Study Network (G03/103).

Arch Intern Med. 2005 Jul 11;165(13):1533-40.

PMID:
16009870
[PubMed - indexed for MEDLINE]
7.

A 5-year longitudinal follow-up study of serological responses to 23-valent pneumococcal polysaccharide vaccination among patients with HIV infection who received highly active antiretroviral therapy.

Hung CC, Chang SY, Su CT, Chen YY, Chang SF, Yang CY, Liu WC, Wu CH, Chang SC.

HIV Med. 2010 Jan;11(1):54-63. doi: 10.1111/j.1468-1293.2009.00744.x. Epub 2009 Jul 29.

PMID:
19659943
[PubMed - indexed for MEDLINE]
8.

Invasive pneumococcal disease in HIV-infected adults in France from 2000 to 2011: antimicrobial susceptibility and implication of serotypes for vaccination.

Munier AL, de Lastours V, Varon E, Donay JL, Porcher R, Molina JM.

Infection. 2013 Jun;41(3):663-8. doi: 10.1007/s15010-013-0419-x. Epub 2013 Feb 13.

PMID:
23404685
[PubMed - indexed for MEDLINE]
9.

Clinical experience of the 23-valent capsular polysaccharide pneumococcal vaccination in HIV-1-infected patients receiving highly active antiretroviral therapy: a prospective observational study.

Hung CC, Chen MY, Hsieh SM, Hsiao CF, Sheng WH, Chang SC.

Vaccine. 2004 May 7;22(15-16):2006-12.

PMID:
15121313
[PubMed - indexed for MEDLINE]
10.

Serologic response to primary vaccination with 7-valent pneumococcal conjugate vaccine is better than with 23-valent pneumococcal polysaccharide vaccine in HIV-infected patients in the era of combination antiretroviral therapy.

Lu CL, Hung CC, Chuang YC, Liu WC, Su CT, Su YC, Chang SF, Chang SY, Chang SC.

Hum Vaccin Immunother. 2013 Feb;9(2):398-404. Epub 2013 Jan 4.

PMID:
23291936
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

The changing epidemiology of invasive pneumococcal disease in aboriginal and non-aboriginal western Australians from 1997 through 2007 and emergence of nonvaccine serotypes.

Lehmann D, Willis J, Moore HC, Giele C, Murphy D, Keil AD, Harrison C, Bayley K, Watson M, Richmond P.

Clin Infect Dis. 2010 Jun 1;50(11):1477-86. doi: 10.1086/652440.

PMID:
20420501
[PubMed - indexed for MEDLINE]
Free Article
12.

Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy.

Abzug MJ, Pelton SI, Song LY, Fenton T, Levin MJ, Nachman SA, Borkowsky W, Rosenblatt HM, Marcinak JF, Dieudonne A, Abrams EJ, Pathak I; Pediatric AIDS Clinical Trials Group P1024 Protocol Team.

Pediatr Infect Dis J. 2006 Oct;25(10):920-9.

PMID:
17006288
[PubMed - indexed for MEDLINE]
13.

Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study.

Kellner JD, Vanderkooi OG, MacDonald J, Church DL, Tyrrell GJ, Scheifele DW.

Clin Infect Dis. 2009 Jul 15;49(2):205-12. doi: 10.1086/599827.

PMID:
19508165
[PubMed - indexed for MEDLINE]
Free Article
14.

Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine.

Black S, France EK, Isaacman D, Bracken L, Lewis E, Hansen J, Fireman B, Austrian R, Graepel J, Gray S, Klein NP.

Pediatr Infect Dis J. 2007 Sep;26(9):771-7.

PMID:
17721369
[PubMed - indexed for MEDLINE]
15.

Impact of pneumococcal vaccination in Denmark during the first 3 years after PCV introduction in the childhood immunization programme.

Ingels H, Rasmussen J, Andersen PH, Harboe ZB, Glismann S, Konradsen H, Hoffmann S, Valentiner-Branth P, Lambertsen L; Danish Pneumococcal Surveillance Collaboration Group 2009-2010.

Vaccine. 2012 Jun 6;30(26):3944-50. doi: 10.1016/j.vaccine.2012.03.060. Epub 2012 Apr 11.

PMID:
22504662
[PubMed - indexed for MEDLINE]
16.

Persistent high burden of invasive pneumococcal disease in South African HIV-infected adults in the era of an antiretroviral treatment program.

Nunes MC, von Gottberg A, de Gouveia L, Cohen C, Kuwanda L, Karstaedt AS, Klugman KP, Madhi SA.

PLoS One. 2011;6(11):e27929. doi: 10.1371/journal.pone.0027929. Epub 2011 Nov 28.

PMID:
22140487
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.

Lacapa R, Bliss SJ, Larzelere-Hinton F, Eagle KJ, McGinty DJ, Parkinson AJ, Santosham M, Craig MJ, O'Brien KL.

Clin Infect Dis. 2008 Aug 15;47(4):476-84. doi: 10.1086/590001.

PMID:
18627249
[PubMed - indexed for MEDLINE]
Free Article
18.

Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007.

Hsu KK, Shea KM, Stevenson AE, Pelton SI; Massachusetts Department of Public Health.

Pediatr Infect Dis J. 2010 Apr;29(4):289-93. doi: 10.1097/INF.0b013e3181c15471.

PMID:
19935447
[PubMed - indexed for MEDLINE]
19.

Invasive pneumococcal disease a decade after pneumococcal conjugate vaccine use in an American Indian population at high risk for disease.

Weatherholtz R, Millar EV, Moulton LH, Reid R, Rudolph K, Santosham M, O'Brien KL.

Clin Infect Dis. 2010 May 1;50(9):1238-46. doi: 10.1086/651680.

PMID:
20367225
[PubMed - indexed for MEDLINE]
Free Article
20.

Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.

Isaacman DJ, McIntosh ED, Reinert RR.

Int J Infect Dis. 2010 Mar;14(3):e197-209. doi: 10.1016/j.ijid.2009.05.010. Epub 2009 Aug 22. Review.

PMID:
19700359
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk